$QNTA #BreakingNews ! Medolife Rx, Inc. ("Medolife"
(OTCQB: QNTA), announced today that the Company submitted the final clinical trial data to the Dominican Republic (“DR”) Ministry of Health (“MoH”) for approval of QNTA product, Escozine, as a COVID-19 treatment.
https://finance.yahoo.com/news/medolife-rx-su...00052.html